Search Results

Showing results 5401 - 5410 for 2025

Novel Risk Factors for Predicting Immune Effector Cell-Associated

...Friedman A, Tozlu C, Gordillo C, Chan H, Reshef R, Wesley S Journal medRxiv Date Published 01/17/2025...

https://cbic.weill.cornell.edu/publications/novel-risk-factors-predicting-immune-effector-cell-associated-neurotoxicity-syndrome

Grand Opening - Och Spine at NewYork-Presbyterian/The Spiral | Department of Rehabilitation Medicine

...Grand Opening - Och Spine at NewYork-Presbyterian/The Spiral Posted by dcs9001 on January 11, 2025...

https://rehabmed.weill.cornell.edu/grand-opening-och-spine-newyork-presbyterianthe-spiral

Gastrointestinal/Liver Pathology Fellowship | Pathology & Laboratory Medicine

...On or before December 30, 2025 - Issuance of formal offers (12:00pm EST)....

https://pathology.weill.cornell.edu/education/fellowship-programs/gastrointestinalliver-pathology-fellowship

Dr. Arnab Ghosh Discusses Climate and Health Policy at Annual Colloquium | Weill Department of Medicine

...Arnab Ghosh Discusses Climate and Health Policy at Annual Colloquium May 6, 2025 Pictured left to...

https://medicine.weill.cornell.edu/news/dr-arnab-ghosh-discusses-climate-and-health-policy-annual-colloquium

The Joan and Sanford I. Weill Center for Metabolic Health Opens: Bringing Together Experts to Catalyze Discovery in Metabolic Disease | Weill Department of Medicine

...-26 Juniors (PGY-2) 2025-26 Seniors (PGY-3) Recent Graduates Fellowship Training Programs Postdoctoral...

https://medicine.weill.cornell.edu/news/joan-and-sanford-i-weill-center-metabolic-health-opens-bringing-together-experts-catalyze

Oral GLP-1 Drug Orforglipron Promotes Substantial Weight Loss in Clinical Trial | Newsroom | Weill Cornell Medicine

...News Oral GLP-1 Drug Orforglipron Promotes Substantial Weight Loss in Clinical Trial September 18, 2025...

https://news.weill.cornell.edu/news/2025/09/oral-glp-1-drug-orforglipron-promotes-substantial-weight-loss-in-clinical-trial

A novel antagonist of the CCL5/CCR5 axis suppresses the tumor growth and metastasis of triple-negative breast cancer by CCR5-YAP1 regulation. | Microbiology and Immunology

...Submitted by ljc4002 on August 21, 2025 - 3:22pm Title A novel antagonist of the CCL5/CCR5 axis suppresses...

https://microbiology.weill.cornell.edu/novel-antagonist-ccl5ccr5-axis-suppresses-tumor-growth-and-metastasis-triple-negative-breast-cancer

Past Events | Page 4 | Enterprise Innovation

...Summer 2025 Prototyping Hardware Accelerator Friday, March 28, 2025 - 9:00am to 5:00pm Location: Ithaca...

https://innovation.weill.cornell.edu/news-and-events/past-events?page=3

Reappraising the Value of HIV-1 Vaccine Correlates of Protection Analyses. | Microbiology and Immunology

...Submitted by ljc4002 on August 21, 2025 - 3:02pm Title Reappraising the Value of HIV-1 Vaccine Correlates...

https://microbiology.weill.cornell.edu/reappraising-value-hiv-1-vaccine-correlates-protection-analyses

Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target. | Microbiology and Immunology

...Submitted by ljc4002 on August 21, 2025 - 2:44pm Title Optimization of TAM16, a Benzofuran That Inhibits...

https://microbiology.weill.cornell.edu/optimization-tam16-benzofuran-inhibits-thioesterase-activity-pks13-evaluation-toward-preclinical

Showing results 5401 - 5410 for 2025